Shows
EyeluminariesEyes on Washington: How the latest news is affecting eye careIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in t...2025-04-2241 min
EyeluminariesLive from Hawaiian Eye 2025In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA. Welcome to the Eyeluminaries podcast :02 Review of episode 30 3:23 Intro of Paul Singh, MD 3:40 What are the future trends in glaucoma you’re most excited about? 5:10 What challenges do you see in running your practice that didn’t exist in your dad’s day? 8:36 You’ve got a great medical office, a very busy consulting and research practice, you play in a band and you have a you...2025-02-061h 00
EyeluminariesThe Latest News and Notes, plus Conversation with Steven Dell, MDIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Steven Dell, MD, about his career and the creation of markets in the field of ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 29 1:28 Bausch + Lomb acquires Elios Vision 2:07 ImprimisRx awarded $34.9 million in trademark infringement suit against OSRX 5:00 Study of atropine-based myopia treatment fails to meet primary efficacy endpoint 7:31 Intro of Steven Dell, MD 11:20 You have created markets with new technologies and companies. Can that continue in today’s market? 13:28 Dell discusses presbyopia market development. 14:11 You created a questionn...2024-12-2635 min
Mend the Gap: Equity in Medicine"Humanitarian work in eye care" -- Crossover with Eyeluminaries PodcastIn this special crossover episode, Eyeluminaries hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are joined live by Susan MacDonald, MD, and Cathleen McCabe, MD, at Eyecelerator 2024 in Chicago, IL. Intro :07 Welcome to the Eyeluminaries podcast 3:14 In this episode 5:02 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 5:11 What started you on this journey to do humanitarian work? 5:30 MacDonald discusses the role of parents in defining of happiness. 10:56 Hovanesian discusses the background of his humanitarian work in Armenia. 11:36 What about the funding of these humanitarian projects? 12:50 What are your stories from doing humanitarian work? 14:11 What advice to do you h...2024-12-1835 minMend the Gap: Equity in Medicine"Humanitarian work in eye care" -- Crossover with Eyeluminaries PodcastIn this special crossover episode, Eyeluminaries hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are joined live by Susan MacDonald, MD, and Cathleen McCabe, MD, at Eyecelerator 2024 in Chicago, IL. Intro :07 Welcome to the Eyeluminaries podcast 3:14 In this episode 5:02 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 5:11 What started you on this journey to do humanitarian work? 5:30 MacDonald discusses the role of parents in defining of happiness. 10:56 Hovanesian discusses the background of his humanitarian work in Armenia. 11:36 What about the funding of these humanitarian projects? 12:50 What are your stories from doing humanitarian work? 14:11 What advice to do you h...2024-12-1835 min
EyeluminariesLive from AAO Eyecelerator 2024: Humanitarian work in eye careIn this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, are live from Eyecelerator with Mend the Gap hosts Susan MacDonald, MD, and Cathleen McCabe, MD, discussing their humanitarian work. Welcome to the Eyeluminaries podcast :02 In this episode :31 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 1:00 What started you on this journey to do humanitarian work? 2:18 MacDonald discusses the role of parents in defining of happiness. 7:47 Hovanesian discusses the background of his humanitarian work in Armenia. 8:24 What about the funding of these humanitarian projects? 9:38 What are your stories from doing humanitarian work? 10:59 What advice to do you h...2024-11-2630 min
EyeluminariesThe Latest News and Notes, plus Conversation with Tom MitroIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 26 :58 FDA grants fast track designation to brepocitinib for noninfectious uveitis 1:42 I. Howard Fine, MD, esteemed ophthalmologist, dies 3:54 First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia 5:48 LENZ Therapeutics submits NDA for drops to treat presbyopia 7:57 Intro of Tom Mitro 10:40 Tell us about your journey in ophthalmology 12:38 Tell us about the new dry eye drug from Signal 12. 15:53 How much s...2024-10-3034 min
CRST: The PodcastDriving Sustainability in Cataract SurgeryIn this episode of CRST: The Podcast, John A. Hovanesian, MD, hosts Emily Schehlein, MD, to explore actionable steps for reducing waste in cataract surgery. Dr. Schehlein shares insights from her work with EyeSustain, an initiative focused on making health care delivery and services in ophthalmology more sustainable—both economically and environmentally. From reducing packaging waste and unnecessary supplies to advocating for electronic instructions for use, this conversation highlights how small, data-driven changes can impact sustainability on a global scale. Drs. Hovanesian and Schehlein discuss the EyeSustain pledge and offer practical advice for institutions, clinicians, and administrators to contribute to...2024-10-2924 min
EyeluminariesInnovations in eye care with Steven Schwartz, MD, and Sean Ianchulev, MD (Re-Release)In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care. Welcome to the Eyeluminaries podcast :10 About Steven Schwartz, MD 2:32 The interview 3:16 Discussion of current innovation in cataract surgery including use of AI, imaging and robotics 4:05 Discussion on Schwartz’s involvement in Neurotech MacTel cell-based treatment 6:32 Advances and disappointments in retinal disease treatments? 10:32 How do companies come back from disappointing trial results? 11:07 Why do retina discoveries take so long to develop? 14:31 New dry AMD treatments in development? 15:58 Drug delivery tech...2024-09-0550 min
EyeluminariesThe Latest News and Notes, plus Conversation with Cathleen McCabe, MDIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Cathleen McCabe, MD, about the ASCRS Foundation and role models in ophthalmology; plus, the latest news in eye care. • Welcome to the Eyeluminaries podcast :05 • Review of episode 25 :46 • Bausch + Lomb acquires Trukera Medical 1:32 • CMS proposes cutting physician payments for fifth straight year 4:09 • FDA clears Alcon’s Unity cataract system, Unity vitreoretinal cataract system 7:40 • FDA approves Eylea biosimilar FYB203/Ahzantive 11:07 • Intro of Cathleen McCabe, MD 13:07 • American Society of Cataract and Refractive Surgery (ASCRS) has become an important organization to advocate, educate and organize docto...2024-07-3135 min
EyeluminariesLive from Octane OTF 2024In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Octane OTF with Euan Thomson, PhD, Barry Kuppermann, MD, Jeffry Weinhuff, Ehsan Sadri, MD, FACS, and a special announcement from Rich Small. Welcome to the Eyeluminaries podcast :05 Review of episode 24 1:38 Intro of Euan Thomson, PhD 2:10 What kind of companies did you like working for the most? 3:14 Can you comment on why adoption of digital solutions is slow and what we can do about it? 4:15 Geographically speaking, what is the area that is doing the best to incorporate new practices in medicine? 6:04 Can you ta...2024-06-2849 min
EyeluminariesThe Latest News and Notes, plus Conversation with Jack Holladay, MD, MSEEIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss leadership in eye care with guest Jack T. Holladay, MD, MSEE, FACS. Brought to you by Johns Hopkins University. • Welcome to the Eyeluminaries podcast :21 • Review of episode 23 1:19 • Blog by John A. Hovanesian, MD, FACS 3:10 • Merck to acquire EyeBio 4:14 • FDA approves aflibercept biosimilars Yesafili, Opuviz 6:26 • Aurion Biotech completes enrollment in phase 1/2 corneal edema cell therapy trial 8:43 • Intro of Jack Holladay, MD, MSEE 11:10 • How did you develop a passion for optics? Did you know it was going to be your future? 13:502024-06-1932 min
EyeluminariesLive from ASCRS Eyecelerator 2024In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Terry Kim, MD, and Stephen Lane about their careers and transitions at Alcon. Brought to you by Johns Hopkins University. Welcome to the Eyeluminaries podcast :21 Review of episode 22 1:27 Intro of Stephen Lane 2:41 Intro of Terry Kim, MD 6:02 Lane: Why retire? What’s next? 7:54 Kim: Why the move to the industry? 10:35 Lane: What does a chief medical officer do? What did you learn from the time you went from practice to CMO, and what were some of the surprises? 13:14 Kim: What do you see as...2024-04-1132 min
EyeluminariesThe Latest News and Notes, plus Conversation with Wiley A. Chambers, MDIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news in eye care and chat with Wiley A. Chambers, MD, about his career in the FDA and his plans for retirement. Brought to you by Johns Hopkins University Welcome to the Eyeluminaries podcast :21 Review of episode 21 :50 Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain 2:49 PulseSight Therapeutics launches with focus on non-viral gene therapies 5:31 FDA clears first investigational new drug application for neuropathic corneal pain 7:59 APX3330 ‘promising’ oral treatment option for slowing progression of diabetic retinopathy 10:20 H. Dunbar Hoskins Jr., decorated glauc...2024-03-2839 min
EyeluminariesLive from Hawaiian Eye 2024Quick episode summary John A. Hovanesian, MD, FACS, and Jim Mazzo sit down with guests Eric D. Donnenfeld, MD, Calvin C. Roberts, MD, Mark L. Baum and Jeannette Bankes to discuss private equity, industry breakthroughs and more. Welcome to the Eyeluminaries podcast :00 Review of episode 20 1:16 Intro of Eric D. Donnenfeld, MD 2:06 Understanding the role of private equity: where does it stand and where is it going? 4:22 Do you see a relief in interest rates and the pace picking up for private equity in the years ahead? 7:19 What are the technologies that you are most excited about? 8:17...2024-02-2348 min
Peer2Peer: The PodcastOMIDRIA Special Ep. 6 Innovations in Dropless Cataract Surgery SolutionsIn this episode of ‘Peer2Peer: The Podcast’, Dr. Eric Donnenfeld and Dr. John Hovanesian discuss a recent clinical study evaluating clinical efficacy and patient preference for a dropless treatment regimen following cataract surgery, as well as other innovative dropless solutions.
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give in...2024-02-0627 minCRST: The PodcastRefractive Lensectomy: Innovations and Patient-Centric CareJoin John A. Hovanesian, MD; George O. Waring IV, MD, FACS; and Beeran Meghpara, MD, as they take an in-depth look at the latest advancements in refractive lensectomy. Topics include differentiating dysfunctional lens syndrome from cataracts, the impact of these conditions on patient counseling, and the intersection of financial and ethical considerations in surgery. Learn more about Shifting Toward Refractive Lensectomy in the October 2023 issue of CRST: https://crstoday.com/articles/oct-2023/i-have-seen-the-future-of-vision-correction-and-its-name-is-refractive-lensectomy?single=true.2023-12-1431 min
EyeluminariesLive from AAO Eyecelerator 2023Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Vance Thompson, MD, Adrienne Graves, PhD, Sean Ianchulev, MD, and Kristen Harmon Igenito, live from AAO Eyecelerator. Welcome to the Eyeluminaries podcast :01 Review of episode 19 1:31 Intro of Vance Thompson, MD 2:13 What is the secret to your success? 3:54 How many fellows have you trained? 5:20 How has having a fellowship training program at Vance Thompson Vision impacted your practice? 6:23 What are the two recently approved products that you are amazed by? 10:02 What is your favorite wine? 12:55 What is your favorite dad joke? 15:25 Intro of Adrienne Graves, PhD 16:59 How does...2023-11-131h 02
EyeluminariesLive from OSN New York 2023Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Peter Slack, Greg Kunst, Rich Small and Uday Devgan, MD, FACS, FRCS, live from OSN New York. Welcome to the Eyeluminaries podcast :01 Review of episode 18 :18 Intro of Peter Slack 1:47 How did OSN start? 2:35 When did you get into meetings and where do you see meetings going? 5:40 Where do you see media going? 7:46 How did you end up running the Hawaiian Eye Meeting? 10:53 Intro of Greg Kunst 13:59s What will be the biggest challenges introducing a new paradigm for a traditionally surgical disease? 14:52 What can you tell us...2023-10-1343 min
EyeluminariesThe Latest News and Notes, plus Conversation with Julia Haller, MDHosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Julia Haller, MD, about the latest developments in retina, residency training and more. Welcome to the Eyeluminaries podcast :01 Review of episode 17, live from Octane OTF :41 Bausch + Lomb makes a number of big moves under the new Brent Saunders regime 1:40 Mark Baum and Harrow Health have also been making a number of acquisitions 3:59 FDA approves Xdemvy for Demodex blepharitis treatment 5:45 Former CEO of Johnson & Johnson Alex Gorsky elected lead director of Neurotech’s board 7:47 John begins new clinical committee for ASCRS, digital 9:32 Julia Haller, MD introduction 11:30 ReST Committee up...2023-09-2930 min
Cataract Coach with Uday Devgan MDCataractCoach PodCast 22: John Hovanesian MD
John Hovanesian MD is in private practice in Orange County, California and he has been involved with ophthalmic teaching, consulting, and giving back for more than 20 years. He also hosts the Eyeluminaries podcast, gets involved in many clinical trials, and authors articles and books in ophthalmology. Our discussion is two long time friends catching up with each other because I've known John since I was a first year ophthalmology resident and he was a cornea fellow. There are some great pearls in this podcast that will help our younger audience maximize their happiness and success. 2023-08-271h 07CRST: The PodcastPhysician-Entrepreneurship in OphthalmologyJoin host Richard L. Lindstrom, MD, as he dives into the world of physician-entrepreneurship in ophthalmology with guests Ashley Brissette, MD, MSc, FRCSC; Ranya Habash, MD; and John A. Hovanesian, MD. Together, they explore the stages of launching a startup as an ophthalmologist—from identifying unmet needs to navigating financial backing and industry partnerships to balancing clinical practice against business ambitions. Learn how these trailblazers are reshaping the future of patient care, overcoming challenges, and pushing the boundaries of innovation in ophthalmology. For more on this topic, check out the May issue of CRST: https://crstoday.com/articles/may-2023.2023-06-2847 min
EyeluminariesLive from OCTANe OTS 2023Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at OCTANe OTS with Mark Leahey, Brent Saunders, Yari Mitchell and Robert Dempsey, discussing their experiences and influence across the ophthalmic space. · Welcome to the Eyeluminaries podcast :01 · Review of episode 16 with Stephen McLeod, MD :28 · Preview of episode 17, live at Octane OTS 1:00 · Introduce Mark Leahey, president & CEO for the Medical Device Manufacturers Association 1:23 · Challenges in medical device 2:19 · Is it possible for the government to reduce regulation of medical devices while still protecting patients? 4:32 · What is MDMA doing for sustainability? 6:50 · ...2023-06-1544 min
EyeluminariesThe Latest News and Notes, plus Conversation with Stephen McLeod, MDHosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Stephen McLeod, MD, about his new position and the future of the American Academy of Ophthalmology. · Welcome to the Eyeluminaries podcast :01 · Review of episode 15, live from Eyecelerator :37 · Preview of episode 17, live at Octane OTS 1:07s · Théa to acquire seven branded ophthalmic products from Akorn 2:17 · FDA approves Miebo to treat signs, symptoms of dry eye disease 5:11 · OCS-01 eye drops meet primary, secondary endpoints in diabetic macular edema phase 3 trial 8:56 · ‘One of my greatest honors’: Jim Mazzo awarded Ellis Island Medal of Honor 10:382023-06-0137 min
EyeluminariesLive from Eyecelerator 2023Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at the Eyecelerator 2023 with five special guests to discuss the future and developments in eye care. · Welcome to the Eyeluminaries podcast :00 · Preview of episode 15 :32 · Review of episode 14, STAAR Surgical :40 · Nick Curtis, CEO of Lensar 1:41 · Lensar is a unique company with loyal customers. How have you achieved that? 3:21 · What are the positives and challenges to not having a large organization as support? 4:09 · Where do you see the company and its products evolving over the next 5 years? 8:01 · Do you think the com...2023-05-0554 min
EyeluminariesConversation with Tom Frinzi, Warren Foust and Magda Michna about STAAR SurgicalHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the new leadership at STAAR Surgical with Tom Frinzi, president and CEO; Warren Foust, COO; and Magda Michna, PhD. • Welcome to the Eyeluminaries podcast :00 • Review of episode 13 with Gil Kliman, MD :23 • Review of episode 12, the Annual Drug Name Awards :52 • Preview of episode 14 1:20 • Tom Frinzi, president and CEO; Warren Foust, COO; and Magda Michna, PhD, introduction 1:28 • Tom: What were the qualities and factors that made you choose Foust and Michna to join the STAAR Surgical team? 3:42 • Magda: Why STAAR Surgical? 6:07 • Magda: What can you do to help repair t...2023-04-2431 min
EyeluminariesConversation with Gil Kliman, MD, about Silicon Valley BankHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the Silicon Valley Bank collapse and its impact on investing and innovation in the field of ophthalmology with Gilbert H. Kliman, MD. · Welcome to the Eyeluminaries podcast :01 · Review of episode 12 with Richard L. Lindstrom, MD :30 · Preview of episode 13 1:35 · Gil Kliman, MD, introduction 2:36 · History of Silicon Valley Bank 4:25 · Silicon Valley Bank’s collapse 6:08 · Guest welcome 8:07 · Was the collapse a surprise? 8:22 · Kliman on major themes of this event being how fast it happened and how unprecedented it was for companies 9:34 · ...2023-03-1527 min
EyeluminariesThe Latest News and Notes, plus Conversation with Richard L. Lindstrom, MDHosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Richard L. Lindstrom, MD, about the latest news and trends, as well as his career and his advice for residents and entrepreneurs in the field of ophthalmology. Welcome to the Eyeluminaries podcast :00 OTF Meeting 01:41 Gezundheit award – Iheezo (chloroprocaine hydrochloride ophthalmic gel) 4:04 Name stolen from a birthday party magician award – Vabysmo (faricimab-svoa) 4:42 The incomplete sentence award – Iyuzeh (latanoprost ophthalmic solution) 5:21 Big improvement on the generic name award – Zimura (avacincaptad pegol) 6:24 Best of the year award – Pegcetacoplan 6:49 Near miss award – Beovu (brolucizumab) 8:08 Awful award – Byooviz (ranibizumab-nuna) 8:45 Guest welcome 9:40 Richard L. Lindstrom, MD, introduction 10:31 FDA grants fa...2023-02-2037 min
EyeluminariesThe Latest News and Notes, live from Hawaiian EyeHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest news stories, live from Hawaiian Eye. Welcome to the Eyeluminaries podcast :01 Review of episode 10, the Allergan alumni guests 1:30 Bausch + Lomb announces acquisition of AcuFocus 3:39 Mazzo attributes success to people and the magic of ophthalmology 5:40 Keranova’s PhotoEmulsification technique shows promising results 9:25 Centricity CEO discusses latest cataract surgery products 11:04 Orasis submits new drug application for presbyopia drop 12:30 Aldeyra submits NDA for primary vitreoretinal lymphoma treatment 15:27 Iveric Bio submits final part of Zimura new drug application for rolling review 17:30 Tom Frinzi to become CEO of STAAR Surgical 22:37 Wrap up...2023-02-0128 min
EyeluminariesThe Latest News and Notes, plus Conversation with Allergan alumniHosts Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Gavin Herbert, Tom Burns, Andy Corley and Tom Mitro to discuss their days at Allergan and what they have learned from their experiences. Welcome to the Eyeluminaries podcast :37 News and notes with John and Jim 1:01 Viatris to acquire Oyster Point, Famy Life Sciences 1:06 Ocuphire enters global license agreement with Famy for Nyxol development 4:20 Eyenuk secures $26 million in Series A funding 6:24 Encapsulated cell therapy shows positive results for macular telangiectasia 8:31 Introduction of the Allergan alumni 10:35 The interview 12:10 Gavin Herbert – what is the secret to great leadership? 12:18 Tom Bu...2023-01-2334 min
EyeluminariesThe Latest News and Notes, plus Conversation with the Schallhorn familyHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Steve Schallhorn, MD, Julie Schallhorn, MD, Craig S. Schallhorn, MD, Erin Schallhorn and Eileen Schallhorn. Welcome to the Eyeluminaries podcast :01 A preview of the guests :32 A review of the previous episode 1:32 News and notes with John and Jim 1:52 Iantrek raises $23 million for MIGS device trials 1:57 Q&A: Data show safety of in-office ophthalmic surgery 4:34 TearLab rebrands as Trukera Medical 7:04 Coherus to launch ranibizumab biosimilar in October 10:46 Introduction of the Schallhorn family 14:38 The interview 16:29 Steve Schallhorn, MD – naval aviator and Top Gun 17:04 Ei...2022-10-1340 min
EyeluminariesThe Latest News and Notes, plus Conversation with Sean Ianchulev, MD, MPHHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Sean Ianchulev, MD, MPH. Welcome to the Eyeluminaries podcast :01 A review of the previous episode :23 News and notes with John and Jim 1:31 Alcon to acquire Aerie Pharmaceuticals 1:40 Glaukos, iVeena enter licensing agreement for keratoconus treatment 5:20 Lions Eye Institute to acquire SightLife 8:37 Novaliq submits NDA for CyclASol for treatment of dry eye disease 11:37 AbbVie, iSTAR enter alliance to support MINIject MIGS device 13:30 Introduction of Sean Ianchulev 16:30 The interview 18:37 Impact on Google Glass 21:32 What innovations are you proud of and what projects are...2022-09-1440 min
EyeluminariesThe Latest News and Notes, plus Conversation with David F. Chang, MDHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview David F. Chang, MD. Welcome to the Eyeluminaries podcast :10 A review of the previous episode :30 News and notes with John and Jim 1:15 AMA president outlines 5 actions for policymakers to take to support physicians 1:20 Aetna drops prior authorization requirement for cataract surgery 4:10 Yutiq approved in China 6:21 Lensar received FDA 510(k) clearance for its next-generation Ally adaptive cataract treatment system 8:55 Introduction of David F. Chang, MD 10:30 The interview 11:48 How did EyeSustain develop and how can people become involved? 13:54 What are you doing differently...2022-08-0835 min
EyeluminariesThe Latest News and Notes, plus Conversation with Allison W. Shuren, JD, MSNHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Allison W. Shuren, JD, MSN. Welcome to the Eyeluminaries podcast :10 A review of the previous episode :30 News and notes with John and Jim 1:20 On the return of in-person medical meetings 1:28 Byooviz, biosimilar to Lucentis, to be available July 1 2:40 First patient dosed in the phase 3 registrational COMET-2 study of AR-15512 for the treatment of dry eye disease signs and symptoms 5:50 Apellis Pharmaceuticals submitted a new drug application to the FDA for intravitreal pegcetacoplan, for the treatment of geographic atrophy secondary to age-related...2022-07-2833 min
EyeluminariesThe Latest News and Notes, plus Conversation with Eve J. Higginbotham, SM, MD, MLHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Eve Higginbotham, MD. Welcome to the Eyeluminaries podcast :10 A review of the previous episode :30 News and notes with John and Jim 1:20 The FDA approved STAAR Surgical’s EVO/EVO+ Visian implantable Collamer lens for the correction of myopia and myopia with astigmatism 1:28 News on two new drop treatments for presbyopia, Visus’ Brimochol PF and Allergan/AbbVie’s Vuity 4:56 Ocuphire’s Nyxol reduced pharmacologically induced mydriasis 7:12 Axim Biotechnologies rapid test for dry eye inflammatory biomarker 9:20 Representation in medicine fails to reflect diversifying U.S. pop...2022-05-0936 min
EyeluminariesThe Latest News and Notes, plus Conversation with Steven Schwartz, MDSteven Schwartz, MD, sits down with hosts, Jim Mazzo and John A. Hovanesian, MD, FACS, to discuss the advances and disappointments in retinal disease treatments, innovations in cataract surgery and more. Welcome to the Eyeluminaries podcast :10 A review of the previous episode :42 News and notes with John and Jim 1:57 Alcon announces fourth-quarter earnings statement 2:03 FDA approves J&J Vision AcuVue Theravision contact lens with ketotifen 6:25 Enhanced monofocal IOLs gaining popularity in Europe 8:47 Ophthalmologists participating in clinical trials 11:30 About Steven Schwartz 12:53 The interview 13:40 Discussion of current innovation in cataract surgery including use of AI, imaging and robotics 14:25 Discussion on...2022-04-0438 min
EyeluminariesThe Latest News and Notes, plus Conversation with Eric Rosenberg, DOIn this episode, hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest news in eyecare, then speak with Eric Rosenberg, DO, about the current state and future of digital ophthalmology. Intro :10 Brief recap of episode 2 with Nicole Fram :55 News and Notes 1:31 Generic of Allergan’s Restasis by Mylan Pharmaceuticals and discussion of generics in the ophthalmic space 2:05 Aramis Biosciences in phase 2 neuromodulator dry eye program and discussion of dry eye 5:12 Jim discusses Aetna’s prior authorization for cataract surgery 6:54 Bilateral same day cata...2022-03-0433 min
EyeluminariesThe Latest News and Notes, plus Conversation with Nicole R. Fram, MDNicole Fram, MD, MPH, is a wearer of many hats and seems to be able to wear them all well. In this episode, she sits down with hosts, Jim Mazzo and John A. Hovanesian, MD, FACS, to discuss taking over as managing partner for Advanced Vision Care and Samuel Masket, MD, balancing her many professional roles, and shares her point of view on new and upcoming products and technologies in eye care. Welcome to the Eyeluminaries podcast :10 News and notes with John and Jim 1:07 Alcon completes acquisition of Ivantis 1:11 FDA approves Genentech’s Vabysmo for AMD, DME 3:54 Sight Sc...2022-02-0737 min
EyeluminariesThe Latest News and Notes, plus Conversation with David W. Parke II, MDIn this episode, David W. Parke II, MD, sits down with hosts, Jim Mazzo and John A. Hovanesian, MD, FACS, to discuss stepping down as the American Academy of Ophthalmology CEO, the highlights of what he accomplished during this time, and his thoughts on the future of ophthalmology. Welcome to the Eyeluminaries podcast :10 News and notes with John and Jim 1:30 Allergan’s Vuity presbyopia-correcting drop gains FDA approval 1:36 Glaukos’ two phase 2 clinical trials for dry eye disease and presbyopia 3:30 Acufocus’ receives “approvable” letter on IC-8 IOL 5:42 Harrow Health acquires four ophthalmic drugs from Novartis 8:40 Welcome David Parke 10:54 What’s it like ha...2022-02-0241 min
EyeluminariesComing Soon from Healio: EyeluminariesIn each episode, your hosts John A. Hovanesian, MD, and Jim Mazzo explore the latest news and trends with newsmakers and visionaries in eye care. Hovanesian is OSN Associate Medical Editor and in private practice at Harvard Eye Associates in Laguna Beach, California Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss Meditec and AMO.2022-02-0100 min
OIS Podcast | Ophthalmology's leading PodcastJohn Hovanesian, MD, on Business, Life, Trends, IOL Technology, and MoreThe OIS Podcast takes another step forward by posting on both iTunes and YouTube. Listen to or watch this entertaining exchange between host Ehsan Sadri, MD, and John Hovanesian, MD, as Dr. Hovanesian enlightens us with some of his principles in life and business, the pain points that his company, MDbackline, is addressing, future trends in patient care, and intraocular lens technologies that he’s bullish about.Dr. Hovanesian also supplies our Quote of the Week: “The enemy of innovation is high margins.”2020-06-2531 min
Ophthalmology off the GridThe Sport of SurgeryHost Gary Wörtz, MD, talks with Ashley Brissette, MD, MSc, FRCSC, and John Hovanesian, MD, about what physicians can do to keep their minds and bodies in peak condition for performing surgery.2019-08-2047 min
Ophthalmology off the GridIn the Windy CityLive from the 2018 AAO meeting in Chicago, host Gary Wörtz, MD, catches up with John Hovanesian, MD, and David Goldman, MD. Drs. Hovanesian and Goldman comment on the new IOL technologies changing the cataract space, the importance of creating a positive practice environment, and the potential impact of MIGS, private equity, and more.2018-10-3044 min